PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1916495
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1916495
Veterinary Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of veterinary drugs Market
The global veterinary drugs market plays a vital role in safeguarding animal health, ensuring food security, and controlling zoonotic disease transmission. According to the report timeline, the global veterinary drugs market size was valued at USD 30.54 billion in 2025. Supported by rising animal disease prevalence, expanding pet ownership, and growing demand for animal-derived protein, the market is projected to grow to USD 32.20 billion in 2026. Over the long-term forecast period, the market is expected to reach USD 53.05 billion by 2034, reflecting steady and sustained growth across both companion and livestock animal segments.
Veterinary drugs are used to prevent, diagnose, mitigate, and treat diseases in animals while supporting optimal physiological functions. These drugs include anti-infectives, parasiticides, anti-inflammatory agents, and other therapeutic categories that address widespread animal health issues such as bovine respiratory disease, foot-and-mouth disease, avian influenza, mastitis, parasitic infestations, and dermatological disorders. The rising frequency of zoonotic and infectious diseases globally continues to reinforce the importance of effective veterinary therapeutics.
Market Dynamics
A major driver of the veterinary drugs market is the rising prevalence of veterinary diseases across livestock and companion animals. Increased disease incidence has led to higher demand for preventive and therapeutic treatments, especially in regions with large livestock populations and dense animal farming practices. Governments and animal health organizations are actively supporting vaccination programs, disease surveillance, and awareness initiatives, further boosting drug adoption.
Another significant growth driver is the increase in pet ownership and humanization of companion animals. Pet owners increasingly view animals as family members and are willing to invest in advanced veterinary care, routine medications, and preventive treatments. This trend has expanded demand for premium veterinary drugs, including biologics, monoclonal antibodies, and pain management therapies.
However, the market faces restraints due to the presence of illegal and counterfeit veterinary medicines. Unauthorized products pose risks to animal health, food safety, and public health by contributing to antimicrobial resistance and undermining trust in regulated pharmaceuticals. Regulatory bodies continue to intensify enforcement efforts to curb illegal drug circulation.
Market Opportunities and Challenges
The growing global pet population and rising disposable income present strong opportunities for veterinary drug manufacturers. Increased spending on routine veterinary care, vaccinations, and chronic disease management is creating demand for innovative and specialized drugs. Expansion of veterinary services in emerging economies further supports market potential.
Conversely, the market faces challenges related to antimicrobial resistance (AMR). Overuse and misuse of antibiotics in animals have accelerated resistance development, prompting stricter regulatory guidelines and reduced antibiotic usage. While these measures improve long-term sustainability, they may limit short-term growth for certain drug classes.
Market Trends
A prominent trend shaping the veterinary drugs market is the emergence of advanced therapies, including gene therapy, monoclonal antibodies, and cell-based treatments. These innovations enable targeted and personalized treatment for complex animal diseases while reducing adverse effects. Another notable trend is the shift toward sustainable veterinary practices, with manufacturers focusing on environmentally friendly formulations and reduced ecological impact of parasiticides.
Segmentation Insights
By product type, parasiticides dominated the market, accounting for the largest share due to widespread parasite infestations in livestock and companion animals. Anti-inflammatory drugs held the second-largest share, driven by rising osteoarthritis and post-surgical pain management needs in pets. Anti-infectives continue to play a critical role, particularly in livestock disease control.
By animal type, the companion animal segment dominated the market, supported by increasing pet ownership, higher healthcare spending, and growing awareness of preventive care. The livestock segment also maintained a strong share due to rising global demand for meat, dairy, and aquaculture products.
By route of administration, oral veterinary drugs held the dominant market share, attributed to ease of administration and high owner compliance. Parenteral formulations are gaining traction for their rapid efficacy, while topical and aerosol routes maintain niche usage.
By distribution channel, veterinary hospitals held the largest share, driven by availability of advanced treatment facilities and specialized veterinary professionals. Clinics and pharmacies continue to expand access to routine veterinary medicines.
Regional Outlook
North America dominated the veterinary drugs market with a 38.57% share in 2025, supported by high pet ownership rates, advanced veterinary infrastructure, and strong R&D activity. Europe follows with steady growth driven by rising pet adoption and regulatory emphasis on responsible drug use. Asia Pacific is emerging as a high-growth region due to expanding livestock farming, increasing disposable income, and government-supported animal health programs. Latin America and the Middle East & Africa are witnessing moderate growth, supported by livestock production expansion and rising demand for animal protein.
Competitive Landscape
The veterinary drugs market is moderately consolidated, with key players such as Zoetis Services LLC, Elanco Animal Health Incorporated, Merck Animal Health, Boehringer Ingelheim International GmbH, and Virbac focusing on R&D investment, product innovation, and strategic acquisitions to strengthen their market positions.
Strictly aligned with the report years 2025, 2026, and 2034, the global veterinary drugs market demonstrates stable growth momentum, supported by rising animal health awareness, expanding companion animal care, and continuous advancements in veterinary therapeutics.
Conclusion
The global veterinary drugs market is on a stable growth trajectory, underpinned by rising animal disease prevalence, expanding pet ownership, and increasing demand for safe and high-quality animal protein. Valued at USD 30.54 billion in 2025, the market's growth to USD 32.20 billion in 2026 reflects steady adoption of preventive and therapeutic solutions across companion and livestock animals. The long-term outlook, reaching USD 53.05 billion by 2034, highlights the sustained importance of veterinary pharmaceuticals in animal health management and food security.
Key growth drivers include heightened awareness of animal healthcare, government-backed disease control initiatives, and the growing humanization of companion animals, which is driving demand for advanced and premium therapies. At the same time, challenges such as antimicrobial resistance and the circulation of illegal veterinary medicines are prompting stricter regulations and more responsible drug usage. Regionally, North America maintains leadership, while Asia Pacific is emerging as a high-growth market supported by livestock expansion and rising incomes. Overall, strictly aligned with the report years 2025, 2026, and 2034, the veterinary drugs market is expected to remain resilient, innovation-driven, and critical to both animal and public health worldwide.
Segmentation By Product
- Anti-infectives
- Anti-Inflammatory
- Parasiticides
- Others
By Animal Type
- Companion
- Feline
- Canine
- Avian
- Others
- Livestock
- Poultry
- Porcine
- Bovine
- Others
By Route of Administration
- Oral
- Parenteral
- Topical
- Aerosol
By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies & Drug Stores
- Others
By Region
- North America (By Product, Animal, Route of Administration, Distribution Channel, Country/Sub-Region)
- U.S.
- Canada
- Europe (By Product, Animal, Route of Administration, Distribution Channel, Country/Sub-Region)
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- Asia Pacific (By Product, Animal, Route of Administration, Distribution Channel, Country/Sub-Region)
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Product, Animal, Route of Administration, Distribution Channel, Country/Sub-Region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Product, Animal, Route of Administration, Distribution Channel, Country/Sub-Region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Overview of Animal Diseases by Key Countries, By Key Countries/ Region, 2026
- 4.2. Pipeline Analysis
- 4.3. Regulatory Scenario By Key Countries/ Region, 2026
- 4.4. Pricing Analysis
- 4.5. Pet Ownership Statistics, By Key Countries/ Region, 2026
- 4.6. Snapshot on the Novel & Upcoming Therapies
- 4.7. Overview of Treatment Plans for Different Animal Diseases
- 4.8. New Product Launches, By Key Players
- 4.9. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
- 4.10. Impact of COVID-19 on the Global Veterinary Drugs Market
5. Global Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product
- 5.1.1. Anti-infectives
- 5.1.2. Anti-inflammatory
- 5.1.3. Parasiticides
- 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - By Animal Type
- 5.2.1. Companion
- 5.2.1.1. Feline
- 5.2.1.2. Canine
- 5.2.1.3. Avian
- 5.2.1.4. Others
- 5.2.2. Livestock
- 5.2.2.1. Poultry
- 5.2.2.2. Porcine
- 5.2.2.3. Bovine
- 5.2.2.4. Others
- 5.2.1. Companion
- 5.3. Market Analysis, Insights and Forecast - By Route of Administration
- 5.3.1. Oral
- 5.3.2. Parenteral
- 5.3.3. Topical
- 5.3.4. Aerosol
- 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 5.4.1. Veterinary Hospitals
- 5.4.2. Veterinary Clinics
- 5.4.3. Pharmacies & Drug Stores
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast - Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product
- 6.1.1. Anti-infectives
- 6.1.2. Anti-inflammatory
- 6.1.3. Parasiticides
- 6.1.4. Others
- 6.2. Market Analysis, Insights and Forecast - By Animal Type
- 6.2.1. Companion
- 6.2.1.1. Feline
- 6.2.1.2. Canine
- 6.2.1.3. Avian
- 6.2.1.4. Others
- 6.2.2. Livestock
- 6.2.2.1. Poultry
- 6.2.2.2. Porcine
- 6.2.2.3. Bovine
- 6.2.2.4. Others
- 6.2.1. Companion
- 6.3. Market Analysis, Insights and Forecast - By Route of Administration
- 6.3.1. Oral
- 6.3.2. Parenteral
- 6.3.3. Topical
- 6.3.4. Aerosol
- 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 6.4.1. Veterinary Hospitals
- 6.4.2. Veterinary Clinics
- 6.4.3. Pharmacies & Drug Stores
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product
- 7.1.1. Anti-infectives
- 7.1.2. Anti-inflammatory
- 7.1.3. Parasiticides
- 7.1.4. Others
- 7.2. Market Analysis, Insights and Forecast - By Animal Type
- 7.2.1. Companion
- 7.2.1.1. Feline
- 7.2.1.2. Canine
- 7.2.1.3. Avian
- 7.2.1.4. Others
- 7.2.2. Livestock
- 7.2.2.1. Poultry
- 7.2.2.2. Porcine
- 7.2.2.3. Bovine
- 7.2.2.4. Others
- 7.2.1. Companion
- 7.3. Market Analysis, Insights and Forecast - By Route of Administration
- 7.3.1. Oral
- 7.3.2. Parenteral
- 7.3.3. Topical
- 7.3.4. Aerosol
- 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 7.4.1. Veterinary Hospitals
- 7.4.2. Veterinary Clinics
- 7.4.3. Pharmacies & Drug Stores
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 7.5.1. Germany
- 7.5.2. U.K.
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
8. Asia Pacific Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product
- 8.1.1. Anti-infectives
- 8.1.2. Anti-inflammatory
- 8.1.3. Parasiticides
- 8.1.4. Others
- 8.2. Market Analysis, Insights and Forecast - By Animal Type
- 8.2.1. Companion
- 8.2.1.1. Feline
- 8.2.1.2. Canine
- 8.2.1.3. Avian
- 8.2.1.4. Others
- 8.2.2. Livestock
- 8.2.2.1. Poultry
- 8.2.2.2. Porcine
- 8.2.2.3. Bovine
- 8.2.2.4. Others
- 8.2.1. Companion
- 8.3. Market Analysis, Insights and Forecast - By Route of Administration
- 8.3.1. Oral
- 8.3.2. Parenteral
- 8.3.3. Topical
- 8.3.4. Aerosol
- 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 8.4.1. Veterinary Hospitals
- 8.4.2. Veterinary Clinics
- 8.4.3. Pharmacies & Drug Stores
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 8.5.1. China
- 8.5.2. Japan
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product
- 9.1.1. Anti-infectives
- 9.1.2. Anti-inflammatory
- 9.1.3. Parasiticides
- 9.1.4. Others
- 9.2. Market Analysis, Insights and Forecast - By Animal Type
- 9.2.1. Companion
- 9.2.1.1. Feline
- 9.2.1.2. Canine
- 9.2.1.3. Avian
- 9.2.1.4. Others
- 9.2.2. Livestock
- 9.2.2.1. Poultry
- 9.2.2.2. Porcine
- 9.2.2.3. Bovine
- 9.2.2.4. Others
- 9.2.1. Companion
- 9.3. Market Analysis, Insights and Forecast - By Route of Administration
- 9.3.1. Oral
- 9.3.2. Parenteral
- 9.3.3. Topical
- 9.3.4. Aerosol
- 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 9.4.1. Veterinary Hospitals
- 9.4.2. Veterinary Clinics
- 9.4.3. Pharmacies & Drug Stores
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
10. Middle East & Africa Veterinary Drugs Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product
- 10.1.1. Anti-infectives
- 10.1.2. Anti-inflammatory
- 10.1.3. Parasiticides
- 10.1.4. Others
- 10.2. Market Analysis, Insights and Forecast - By Animal Type
- 10.2.1. Companion
- 10.2.1.1. Feline
- 10.2.1.2. Canine
- 10.2.1.3. Avian
- 10.2.1.4. Others
- 10.2.2. Livestock
- 10.2.2.1. Poultry
- 10.2.2.2. Porcine
- 10.2.2.3. Bovine
- 10.2.2.4. Others
- 10.2.1. Companion
- 10.3. Market Analysis, Insights and Forecast - By Route of Administration
- 10.3.1. Oral
- 10.3.2. Parenteral
- 10.3.3. Topical
- 10.3.4. Aerosol
- 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 10.4.1. Veterinary Hospitals
- 10.4.2. Veterinary Clinics
- 10.4.3. Pharmacies & Drug Stores
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2026)
- 11.2. Company Profiles
- 11.2.1. Zoetis Services LLC
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Merck & Co., Inc.
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Elanco Animal Health Incorporated
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Boehringer Ingelheim International GmbH.
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Ceva
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Vetoquinol
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Dechra Pharmaceuticals Limited
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Virbac Corporation
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.1. Zoetis Services LLC
List of Tables
- Table 1: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
- Table 2: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
- Table 3: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
- Table 4: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
- Table 5: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
- Table 6: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
- Table 7: Global Veterinary Drug Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 8: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
- Table 9: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
- Table 10: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
- Table 11: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
- Table 12: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
- Table 13: North America Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
- Table 14: North America Veterinary Drug Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 15: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
- Table 16: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
- Table 17: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
- Table 18: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
- Table 19: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
- Table 20: Europe Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
- Table 21: Europe Veterinary Drug Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
- Table 22: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
- Table 23: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
- Table 24: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
- Table 25: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
- Table 26: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
- Table 27: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
- Table 28: Asia Pacific Veterinary Drug Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
- Table 29: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
- Table 30: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
- Table 31: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
- Table 32: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
- Table 33: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
- Table 34: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
- Table 35: Latin America Veterinary Drug Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
- Table 36: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Product, 2019-2032
- Table 37: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Animal Type, 2019-2032
- Table 38: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Companion, 2019-2032
- Table 39: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Livestock, 2019-2032
- Table 40: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Route of Administration 2019-2032
- Table 41: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, by Distribution Channel 2019-2032
- Table 42: Middle East & Africa Veterinary Drug Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
List of Figures
- Figure 1: Global Veterinary Drug Market Revenue Breakdown (USD billion, %) by Region, 2026-2034
- Figure 2: Global Veterinary Drug Market Value Share (%), by Product, 2026-2034
- Figure 3: Global Veterinary Drug Market Value Share (%), by Animal Type, 2026-2034
- Figure 4: Global Veterinary Drug Market Value Share (%), by Route of Administration, 2026-2034
- Figure 5: Global Veterinary Drug Market Value Share (%), by Distribution Channel, 2026-2034
- Figure 6: Global Veterinary Drug Market Value (USD billion), by Region, 2026-2034
- Figure 7: North America Veterinary Drug Market Value (USD billion), by Product, 2026-2034
- Figure 8: North America Veterinary Drug Market Value Share (%), by Product, 2026
- Figure 9: North America Veterinary Drug Market Value (USD billion), by Animal Type, 2026-2034
- Figure 10: North America Veterinary Drug Market Value Share (%), by Animal Type, 2026
- Figure 11: North America Veterinary Drug Market Value (USD billion), by Route of Administration, 2026-2034
- Figure 14: North America Veterinary Drug Market Value Share (%), by Route of Administration, 2026
- Figure 13: North America Veterinary Drug Market Value (USD billion), by Distribution Channel, 2026-2034
- Figure 14: North America Veterinary Drug Market Value Share (%), by Distribution Channel, 2026
- Figure 15: North America Veterinary Drug Market Value (USD billion), By Country, 2026-2034
- Figure 16: North America Veterinary Drug Market Value Share (%), By Country, 2026
- Figure 17: Europe Veterinary Drug Market Value (USD billion), by Product, 2026-2034
- Figure 18: Europe Veterinary Drug Market Value Share (%), by Product, 2026
- Figure 19: Europe Veterinary Drug Market Value (USD billion), by Animal Type, 2026-2034
- Figure 20: Europe Veterinary Drug Market Value Share (%), by Animal Type, 2026
- Figure 21: Europe Veterinary Drug Market Value (USD billion), by Route of Administration, 2026-2034
- Figure 22: Europe Veterinary Drug Market Value Share (%), by Route of Administration, 2026
- Figure 23: Europe Veterinary Drug Market Value (USD billion), by Distribution Channel, 2026-2034
- Figure 24: Europe Veterinary Drug Market Value Share (%), by Distribution Channel, 2026
- Figure 25: Europe Veterinary Drug Market Value (USD billion), By Country/Sub-Region, 2026-2034
- Figure 26: Europe Veterinary Drug Market Value Share (%), By Country/Sub-Region, 2026
- Figure 27: Asia Pacific Veterinary Drug Market Value (USD billion), by Product, 2026-2034
- Figure 28: Asia Pacific Veterinary Drug Market Value Share (%), by Product, 2026
- Figure 29: Asia Pacific Veterinary Drug Market Value (USD billion), by Animal Type, 2026-2034
- Figure 30: Asia Pacific Veterinary Drug Market Value Share (%), by Animal Type, 2026
- Figure 31: Asia Pacific Veterinary Drug Market Value (USD billion), by Route of Administration, 2026-2034
- Figure 32: Asia Pacific Veterinary Drug Market Value Share (%), by Route of Administration, 2026
- Figure 33: Asia Pacific Veterinary Drug Market Value (USD billion), by Distribution Channel, 2026-2034
- Figure 34: Asia Pacific Veterinary Drug Market Value Share (%), by Distribution Channel, 2026
- Figure 35: Asia Pacific Veterinary Drug Market Value (USD billion), By Country/Sub-Region, 2026-2034
- Figure 36: Asia Pacific Veterinary Drug Market Value Share (%), By Country/Sub-Region, 2026
- Figure 37: Latin America Veterinary Drug Market Value (USD billion), by Product, 2026-2034
- Figure 38: Latin America Veterinary Drug Market Value Share (%), by Product, 2026
- Figure 39: Latin America Veterinary Drug Market Value (USD billion), by Animal Type, 2026-2034
- Figure 40: Latin America Veterinary Drug Market Value Share (%), by Animal Type, 2026
- Figure 41: Latin America Veterinary Drug Market Value (USD billion), by Route of Administration, 2026-2034
- Figure 42: Latin America Veterinary Drug Market Value Share (%), by Route of Administration, 2026
- Figure 43: Latin America Veterinary Drug Market Value (USD billion), by Distribution Channel, 2026-2034
- Figure 44: Latin America Veterinary Drug Market Value Share (%), by Distribution Channel, 2026
- Figure 45: Latin America Veterinary Drug Market Value (USD billion), By Country/Sub-Region, 2026-2034
- Figure 46: Latin America Veterinary Drug Market Value Share (%), By Country/Sub-Region, 2026
- Figure 47: Middle East & Africa Veterinary Drug Market Value (USD billion), by Product, 2026-2034
- Figure 48: Middle East & Africa Veterinary Drug Market Value Share (%), by Product, 2026
- Figure 49: Middle East & Africa Veterinary Drug Market Value (USD billion), by Animal Type, 2026-2034
- Figure 50: Middle East & Africa Veterinary Drug Market Value Share (%), by Animal Type, 2026
- Figure 51: Middle East & Africa Veterinary Drug Market Value (USD billion), by Route of Administration, 2026-2034
- Figure 52: Middle East & Africa Veterinary Drug Market Value Share (%), by Route of Administration, 2026
- Figure 53: Middle East & Africa Veterinary Drug Market Value (USD billion), by Distribution Channel, 2026-2034
- Figure 54: Middle East & Africa Veterinary Drug Market Value Share (%), by Distribution Channel, 2026
- Figure 55: Middle East & Africa Veterinary Drug Market Value (USD billion), By Country/Sub-Region, 2026-2034
- Figure 56: Middle East & Africa Veterinary Drug Market Value Share (%), By Country/Sub-Region, 2026
- Figure 57: Global Veterinary Drug Market Share (%), By Company, 2026
